CIK 0001446847 · Accelerated filer<br>Smaller reporting company
IRONWOOD PHARMACEUTICALS INC
Sign in to watch- Ticker
- IRWD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043404176
- Phone
- 617-621-7722
- Business address
- 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-17 | MCCOURT Thomas A Chief Executive Officer | Grant or award | +249,617 | 1,009,938 | ||
| 2024-01-17 | Shetzline Michael CMO,SVP,Head-Res&Drug | Grant or award | +57,971 | 379,102 | ||
| 2024-01-17 | John Minardo Chief Legal Officer | Grant or award | +79,981 | 272,176 | ||
| 2024-01-17 | Emany Sravan Kumar SVP, Chief Financial Officer | Grant or award | +85,000 | 267,069 | ||
| 2023-12-15 | Moukheibir Catherine Director | Grant or award | +1,572 | 128,633 | ||
| 2023-12-15 | DENNER ALEXANDER J Director | Grant or award | +1,347 | 120,277 | ||
| 2023-12-14 | Kessler Marla L Director | Sale 10b5-1 | −9,926 | $11.19 | $111K | 96,572 |
| 2023-11-20 | Davis Andrew SVP, Chief Business Officer | Sale | −3,287 | $9.69 | $32K | 217,374 |
Page 7 of 7 · 128 trades